While other treatment strategies most often come into play, diet and exercise are the principal staples in the fight against weight gain and obesity. The role of proper nutrition in maintaining a ...

Metformin may reduce knee pain in overweight patients with osteoarthritis, offering a low-cost alternative to early knee ...

Two in three adults could be obese by 2050, according to world heart report (EMB Sat 17th 00:00) - More than 800 million ...

Mexico's type 2 diabetes crisis, with a prevalence of 16·9%, has made the country a focal point for fiscal policies targeting ...

Weightwatchers and bariatric surgery had limited effects on the obese brain, but GLP-1s like Ozempic may mean new hope in ...

NBC News and MSNBC medical contributor Dr. Kavita Patel joins ‘Fast Money’ to discuss Novo Nordisk after the company ousted ...

While the US leads in early-phase obesity trials and investment, the country also faces challenges in disease burden, trial ...

Septerna's GPCR platform shows promise, but execution risks, funding needs, and competition suggest caution. Click here to ...

Estrogen generated in the brain may play a role in regulating appetite, potentially opening new avenues for treating obesity.

Zepbound outperformed Nordisk's Wegovy in terms of weight loss, solidifying Lilly's leadership in the anti-obesity drug ...

The $7.8 million investment will fund further drug testing and development to advance its drug candidates to clinical trials.

Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...